OSI Pharmaceuticals Overview
- Year Founded
-
1983
- Status
-
Acquired/Merged
- Employees
-
535
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
4
OSI Pharmaceuticals General Information
Description
Manufacturer and seller of cancer medicines based in Melville, New York. The company engages in discovering, developing and commercialization of molecular targeted therapies used in oncology, diabetes and obesity disease. It also manufactures and sells cancer medicine Tarceva.
Contact Information
Website
www.prosidion.comCorporate Office
- 41 Pinelawn Road
- Melville, NY 11747
- United States
Corporate Office
- 41 Pinelawn Road
- Melville, NY 11747
- United States
OSI Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
OSI Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
OSI Pharmaceuticals Patents
OSI Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170273982-A1 | Pulse dosing regimen and methods of treatment | Active | 25-Mar-2016 | ||
| US-10583142-B2 | Pulse dosing regimen and methods of treatment | Active | 25-Mar-2016 | ||
| US-11253520-B2 | Pulse dosing regimen and methods of treatment | Active | 25-Mar-2016 | ||
| US-20200230142-A1 | Pulse dosing regimen and methods of treatment | Active | 25-Mar-2016 | ||
| US-20220133725-A1 | Pulse dosing regimen and methods of treatment | Active | 25-Mar-2016 | A61K31/517 |
OSI Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
OSI Pharmaceuticals Investments & Acquisitions (4)
OSI Pharmaceuticals’s most recent deal was a Later Stage VC with AVEO Oncology for . The deal was made on 25-Jun-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AVEO Oncology | 25-Jun-2009 | Later Stage VC | Biotechnology | ||
| Eyetech Pharmaceuticals | 14-Nov-2005 | Merger/Acquisition | Pharmaceuticals | ||
| Cell Pathways | 12-Jun-2003 | Merger/Acquisition | Biotechnology | ||
| Gilead Sciences (Oncology Assets) | 26-Nov-2001 | Corporate Asset Purchase | Buildings and Property |
OSI Pharmaceuticals Exits (2)
OSI Pharmaceuticals’s most recent exit was on 25-Jun-2009 from AVEO Oncology. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| AVEO Oncology | 25-Jun-2009 | Completed |
|
||
| Eyetech Pharmaceuticals | 14-Nov-2005 | Merger/Acquisition | Completed |
OSI Pharmaceuticals FAQs
-
When was OSI Pharmaceuticals founded?
OSI Pharmaceuticals was founded in 1983.
-
Where is OSI Pharmaceuticals headquartered?
OSI Pharmaceuticals is headquartered in Melville, NY.
-
What is the size of OSI Pharmaceuticals?
OSI Pharmaceuticals has 535 total employees.
-
What industry is OSI Pharmaceuticals in?
OSI Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is OSI Pharmaceuticals a private or public company?
OSI Pharmaceuticals is a Private company.
-
What is the current valuation of OSI Pharmaceuticals?
The current valuation of OSI Pharmaceuticals is .
-
What is OSI Pharmaceuticals’s current revenue?
The current revenue for OSI Pharmaceuticals is .
-
When was OSI Pharmaceuticals acquired?
OSI Pharmaceuticals was acquired on 09-Jun-2010.
-
Who acquired OSI Pharmaceuticals?
OSI Pharmaceuticals was acquired by Astellas Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
